Sponsor pipeline

Monopar Therapeutics clinical trial pipeline

Get alerts when Monopar Therapeutics's trials change

2 active trials 0 recruiting 8 disease areas 4 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-05

What changed in the last 30 days

2026-09-04
Primary completion pushed: 2026-04 → 2026-12
Enrollment closed, study ongoing
Completion pushed: 2026-04 → 2026-12
NCT06337084 Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors · Phase 1
2026-09-04
Enrollment closed, study ongoing
NCT06617169 Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors · Phase 1

Active trials by phase

Phase 1
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1
NCT06337084 Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors Solid Tumor, Adult Active, Not Recruiting 2026-09-03
NCT06617169 Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors Solid Tumor, Adult Active, Not Recruiting 2026-09-03

Disease areas by active trials

Bladder Cancer (2) · Breast Cancer (2) · Colorectal Cancer (2) · Gastric Cancer (2) · Lung Cancer (2) · Ovarian Cancer (2) · Pancreatic Cancer (2) · Triple-Negative Breast Cancer (2)

Get alerts when Monopar Therapeutics's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free